CRISPRX Trademark

Trademark Overview


On Wednesday, March 8, 2023, a trademark application was filed for CRISPRX with the United States Patent and Trademark Office. The USPTO has given the CRISPRX trademark a serial number of 97828587. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, March 25, 2024. This trademark is owned by CRISPR Therapeutics AG. The CRISPRX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to i...
crisprx

General Information


Serial Number97828587
Word MarkCRISPRX
Filing DateWednesday, March 8, 2023
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, March 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of of the term CRISPRX with a line under the letters RISP.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesScientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 28, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCRISPR Therapeutics AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressZUG V8 6300
CH

Trademark Events


Event DateEvent Description
Monday, March 25, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, March 25, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, September 12, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 12, 2023NON-FINAL ACTION E-MAILED
Tuesday, September 12, 2023NON-FINAL ACTION WRITTEN
Tuesday, September 12, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 12, 2023NON-FINAL ACTION E-MAILED
Tuesday, September 12, 2023NON-FINAL ACTION WRITTEN
Friday, July 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 14, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 14, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 13, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, July 13, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, April 14, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 14, 2023NON-FINAL ACTION E-MAILED
Friday, April 14, 2023NON-FINAL ACTION WRITTEN
Friday, March 31, 2023ASSIGNED TO EXAMINER
Wednesday, March 29, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, March 28, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 11, 2023NEW APPLICATION ENTERED